DEPLOYDatabase

Deployment

Remebot at Beijing, China

China's first NMPA-approved neurosurgical robot (Class III, 2018). Features a six-axis robotic arm with CT/MRI-compatible visual imaging system, AI-based image identification, and 0.5mm positioning precision guided by an independent optical navigation system. Used for brain biopsy, hematoma drainage, and deep brain stimulation electrode implantation across 300+ hospitals

Remebot by Remebot · Unverified · Surgical robots

Track Remebot at Beijing, China

Recent coverage

See all coverage →

First clinical use at PLA Navy General Hospital in Beijing. China's first NMPA-approved neurosurgical robot (2018). Now deployed across 300+ hospitals in 31 provinces with 30,000+ clinical operations (company-reported).

Key facts

Fleet size
300+ hospitals across 31 provinces (company-reported)
Clinical operations
Over 30,000 (company-reported)

Safety record

No incidents on record for Remebot at Beijing, China.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Trust tier
Unverifiedhow tiers work →
Last updated
2026-08-04
Model
Remebot
Company
Remebot
Location
Beijing, China
Operator
Remebot
Status
operational
First seen
2018-01-01
ID
2e7480c4-6a3d-4bd8-a5d8-f7d76f8135ac

Timeline

  1. Jan 2018
    First recorded
    Remebot first documented operating at Beijing, China.
  2. Aug 2026
    Current status: operational
    Latest recorded state. New status transitions append here as the deployment-status recorder produces them.

On the deployment map

Remebot operates in Beijing, China. Explore the full verified map:

Sources (1)

  1. https://www.nature.com/articles/d42473-020-00264-z · 2020-07-29
Methodology: Unreviewed · 1 source (1 primary) · last reviewed 2026-08-04

Verification posture

Unreviewed

Low confidence

Review state

Stable

Last reviewed 2026-08-04

Maturity + lifecycle

Maturity stage: production

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
primary-academic-peer-reviewed
Peer-reviewed clinical / academic

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Remebot at Beijing, China.

Common questions

What is the Remebot deployment at Beijing, China?
Remebot, built by Remebot, is recorded as a deployment at Beijing, China on the DEPLOY registry. Remebot operates the deployment directly.
Who operates Remebot at Beijing, China?
Remebot, the manufacturer of Remebot, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
When did the Remebot deployment at Beijing, China go live?
The deployment is recorded as starting January 1, 2018 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
Have there been incidents at the Remebot deployment at Beijing, China?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.

Machine-readable surfaces